Wilmington contract research organization Pharmaceutical Product Development has closed on its buy of Bethesda, Maryland-based research firm Evidera. Deal terms were not disclosed. PPD announced plans to buy the company in August. On Tuesday, execs said the companies would both benefit from the buy. In an interview, Evidera CEO John Williams said his company had been in discussions with PPD since the beginning of the year - and PPD wasn't the only caller. While he says Evidera "was not for...
Evidera is a Maryland-based company that offers services such as medical writing and development consulting for biopharmaceutical and biotechnology markets.